SMR Stock Analysis — Full AI Research Report
NuScale Power Corporation — Institutional-grade analysis powered by Kasiel with 410+ sources.
ANALYSIS
NuScale is the only NRC-design-certified small modular reactor maker, but the stock has collapsed ~78% from its $57 high amid a brutal cocktail of problems: <cite index="42-1,42-2">FY2025 revenue actually declined to $31.5M from $37M in 2024 with a $355.8M net loss</cite>, securities-fraud class actions over alleged ENTRA1 misrepresentations, <cite index="30-2">Fluor's complete ~40M-share strategic exit (~$2.43B since Sept 2025)</cite>, and <cite index="83-2,83-3">heavy ATM dilution (39.3M shares for $750M in Q4 2025 alone)</cite>. The technicals show a stock trying to base near $11–14 with weekly bullish engulfing patterns but trading 50%+ below its $25.85 200-day SMA and well below its $25 VWAP. Macro is mixed — <cite index="79-3">DOE signaling first 5–10 reactors will get federal loans</cite> is a real tailwind for the AI/data-center nuclear thesis, but the Fed's hawkish hold and a 4.42% 10-year yield punish long-duration cash-flow stories. <cite index="32-2">Short interest is 38.92% of float (66.3M shares) — extreme</cite>. The cash floor of ~$836M with essentially no long-term debt buys NuScale survival runway, but with first commercial revenue not until ~2029, no firm construction contracts yet, and a Q1 2026 earnings event May 7, this is a 'show-me' story. WAIT for the May 7 print and clarity on the lawsuit before committing buy-and-hold capital — there will be cheaper or higher-conviction entry points.
WAIT DETAILS
Re-eval: 2026-05-08 (morning after Q1 earnings)- Q1 2026 earnings report (May 7) shows revenue stabilization or pipeline visibility
- No new ATM equity offering in the next 90 days
- ENTRA1 class action shows path to dismissal or capped settlement
- Stock holds the $11.00-$11.10 weekly support OR breaks above $14.00 daily resistance with volume
- Binding (not MOU) construction contract signed with at least one customer
Re-evaluate SMR after May 7 Q1 2026 earnings. Look for: revenue trend, cash burn rate, dilution intent, Romania FID timing, U.S. customer pipeline, lawsuit progression. Be prepared to either commit on a clean catalyst or pass on continued execution risk.
BULL CASE
If Q1 2026 earnings show a firm construction contract and Romania's final investment decision lands in late 2026 with DOE loan support, NuScale can re-rate as the only NRC-certified SMR available for the AI-data-center power buildout. <cite index="82-1">A short squeeze is plausible given 38.92% short interest on 66M shares</cite>. Realistic 12-month upside: $25–35 (median analyst target ~$21, high $63).
BEAR CASE
If the May 7 print shows another large miss, more dilution, or the ENTRA1 lawsuit produces damaging discovery, the stock can revisit the April low of $9.65 or break to $7. <cite index="30-3">Citi has a Sell rating and a $9 target</cite>. With first commercial revenue not arriving until ~2029, every quarter of cash burn is a tax on equity holders. Realistic 12-month downside: $7–9.
EXIT PLAN
- Q1 2026 (May 7) revenue or guidance miss by >25% combined with new dilution
- Romania final investment decision delayed past Q2 2027
- Class-action lawsuit produces an executive resignation or restated financials
- No binding U.S. customer construction contract by year-end 2026
- DOE explicitly excludes NuScale projects from the first 5-10 reactor loans
LEVERAGE PLAY
Position: There is no 2x/3x SMR-specific leveraged ETF. For amplified exposure, single-stock options are the only practical vehicle and should be sized at 25-40% of the equivalent spot allocation given the elevated implied vol.Not leveraged — included as a diversified alternative if SMR-specific risk is unacceptable.
Not leveraged.
Hedging existing long position into the May 7 earnings print or a directional bear bet on the lawsuit overhang.
Single-stock options on a stock with binary lawsuit/earnings outcomes can lose 100% in days. Implied volatility is already pricing big moves, so premium is expensive — directional option buyers face theta decay even if the thesis is right but the timing is wrong.
ASYMMETRIC OPPORTUNITY
If a U.S. hyperscaler signs a binding contract in 2026, Romania reaches FID with DOE loan support, and the lawsuit settles for a manageable amount, SMR could re-rate to $35–60 as the AI-nuclear thesis matures and short covering accelerates. <cite index="82-1">With 39% short interest on 66M shares, a positive surprise can produce a violent squeeze</cite>.
FUNDAMENTALS
Fundamentally weak in the near term: revenue is contracting, cash burn is accelerating, and dilution is running aggressively. The only redeeming features are the strong cash balance, no long-term debt, and the unique NRC design certification — these provide survival runway, not earnings power.
MACRO CONTEXT
Trace: Higher-for-longer Fed (3.5–3.75% policy rate, hawkish hold in April 2026) → 10-year Treasury at ~4.42% → punishes long-duration, unprofitable growth stories like NuScale. <cite index="49-3">Oil pushing toward $120 fuels inflation</cite> which keeps the Fed hawkish, but also fuels the case for nuclear baseload power. AI data-center demand + DOE's $800M nuclear push + Energy Secretary's loan commitments are real sector tailwinds. Net: macro is a mixed bag — sector tailwinds support nuclear long-term but high rates make speculative names like SMR vulnerable to risk-off rotations.
SMART MONEY
<cite index="22-3">Fluor Corp completed full exit of its ~40M-share stake (~$2.43B sold since Sept 2025)</cite>, the loudest possible insider sell signal. <cite index="19-1">COO Carl Fisher sold 49,277 shares at $12.64 on Mar 4, 2026 under a 10b5-1 plan</cite>. <cite index="23-1">Vanguard reported 0 shares in a Jan 12, 2026 Schedule 13G/A realignment</cite>. <cite index="23-2">Insiders booked $162.9M in stock sales between March 24 and April 9, 2026 with zero offsetting buys</cite>. Institutional ownership is ~32.5% (Wallstreetzen) but trending down. Net signal: smart money is leaving, not arriving.
RISK ASSESSMENT
This is a pre-revenue-scale story stock with a securities-fraud class action, accelerating dilution, and its largest strategic shareholder fully exited. Even with $836M+ cash and no long-term debt, the equity could halve again before the thesis bottoms.
“Only NRC-certified SMR maker with cash to survive — but with Fluor gone, lawsuits live, and zero binding revenue contracts, sit on hands until the May 7 earnings print tells you which side of the binary you're on.”
Get Your Own AI Analysis
Analyze any stock, crypto, or ETF with Kasiel. 2 free analyses per month — no credit card required.
Try Kasiel FreeNot financial advice. AI-powered research tool. Always DYOR.